154 related articles for article (PubMed ID: 26792369)
1. Essential psychiatric medicines: wrong selection, high consumption and social problems.
Fulone I; Barberato-Filho S; dos Santos MF; Rossi Cde L; Guyatt G; Lopes LC
BMC Public Health; 2016 Jan; 16():52. PubMed ID: 26792369
[TBL] [Abstract][Full Text] [Related]
2. [Adherence to essential medicines in cities from three Brazilian states].
Dal Pizzol Tda S; Trevisol DJ; Heineck I; Flores LM; Camargo AL; Köenig A; Torres IL; Kadri MC; Monreal MT; Melo AM; Ferreira MB
Cad Saude Publica; 2010 Apr; 26(4):827-36. PubMed ID: 20512222
[TBL] [Abstract][Full Text] [Related]
3. Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?
Osorio-de-Castro CGS; Azeredo TB; Pepe VLE; Lopes LC; Yamauti S; Godman B; Gustafsson LL
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):402-412. PubMed ID: 29117642
[TBL] [Abstract][Full Text] [Related]
4. Withdrawn medicines included in the essential medicines lists of 136 countries.
Charles O; Onakpoya I; Benipal S; Woods H; Bali A; Aronson JK; Heneghan C; Persaud N
PLoS One; 2019; 14(12):e0225429. PubMed ID: 31791048
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. [Medicines prescribed to the elderly in a city in southern Brazil and the Municipal Medicines List].
Aziz MM; Calvo MC; d'Orsi E
Cad Saude Publica; 2012 Jan; 28(1):52-64. PubMed ID: 22267065
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
8. Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study.
Taglione MS; Persaud N
BMJ Open; 2021 Aug; 11(8):e045262. PubMed ID: 34380717
[TBL] [Abstract][Full Text] [Related]
9. National Essential Medicines List and policy practice: a case study of China's health care reform.
Tian X; Song Y; Zhang X
BMC Health Serv Res; 2012 Nov; 12():401. PubMed ID: 23150933
[TBL] [Abstract][Full Text] [Related]
10. Applying the essential medicines concept to US preferred drug lists.
Millar TP; Wong S; Odierna DH; Bero LA
Am J Public Health; 2011 Aug; 101(8):1444-8. PubMed ID: 21680927
[TBL] [Abstract][Full Text] [Related]
11. [The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy].
Yamauti SM; Barberato-Filho S; Lopes LC
Cad Saude Publica; 2015 Aug; 31(8):1648-62. PubMed ID: 26375644
[TBL] [Abstract][Full Text] [Related]
12. The Selection and Use of Essential Medicines.
World Health Organ Tech Rep Ser; 2015; (994):vii-xv, 1-546. PubMed ID: 27183787
[TBL] [Abstract][Full Text] [Related]
13. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
14. Essential medicines for cancer: WHO recommendations and national priorities.
Robertson J; Barr R; Shulman LN; Forte GB; Magrini N
Bull World Health Organ; 2016 Oct; 94(10):735-742. PubMed ID: 27843163
[TBL] [Abstract][Full Text] [Related]
15. The selection and use of essential medicines.
World Health Organization
World Health Organ Tech Rep Ser; 2011; (965):i-xiv, 1-249. PubMed ID: 22891532
[TBL] [Abstract][Full Text] [Related]
16. Comparison of essential medicines lists in 137 countries.
Persaud N; Jiang M; Shaikh R; Bali A; Oronsaye E; Woods H; Drozdzal G; Rajakulasingam Y; Maraj D; Wadhawan S; Umali N; Wang R; McCall M; Aronson JK; Plüddemann A; Moja L; Magrini N; Heneghan C
Bull World Health Organ; 2019 Jun; 97(6):394-404C. PubMed ID: 31210677
[TBL] [Abstract][Full Text] [Related]
17. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
[TBL] [Abstract][Full Text] [Related]
18. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region.
Mehrtash H; Laing R; Wirtz VJ
East Mediterr Health J; 2018 Jul; 24(5):427-434. PubMed ID: 30043961
[TBL] [Abstract][Full Text] [Related]
20. Costs of Public Pharmaceutical Services in Rio de Janeiro Compared to Farmácia Popular Program.
Silva RM; Caetano R
Rev Saude Publica; 2016 Dec; 50():74. PubMed ID: 28099664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
